Together we form a new and strong partnership for the Benelux market. With GD Medical we have won , a company that exclusively distributes market- leading wound products for use in hospitals, nursing homes or at home. They have an experienced, dedicated and specialized team with competent market knowledge.
Jens Kirsch, CEO of terraplasma medical GmbH, is looking forward to the sales cooperation with GD Medical and thus further countries that will benefit from the innovation.
Jens Kirsch, CEO of terraplasma medical
“The foundation for a successful cooperation has been established.”
Roel Claassen, Managing Director of GD Medical, is very excited about the introduction of the plasma care® products in the region.
Roel Claassen, Managing Director of GD Medical
“Cold plasma therapy is going to revolutionize the treatment of patients with chronic wounds in the Benelux countries. The effect of cold plasma has convinced the sales staff of GD Medical with its effectiveness and handling and is the perfect addition to our existing portfolio.”
The use of cold plasma in hospitals, nursing homes and private practices, will provide a future-oriented alternative to existing therapies and be an additional treatment. It reduces the use of antibiotics or cortisone and causes neither side effects, allergic reactions nor pain. It activates cell growth, stimulates blood circulation and cell metabolism and thus stimulates wound healing.
We are talking about a quantum leap in medical technology available for the treatment of acute and chronic wounds as well as dermatological skin diseases. The clinical experience of the last few years has shown that this new form of therapy, in addition to its bactericidal and healing-promoting effect, offers further benefits for the health care system: e.g. a reduction in nursing and dressing costs for chronic wounds or wounds contaminated with multi-resistant pathogens. Through the postoperative use of the devices, a longer hospital admission of the patient can be avoided. By reducing the use of antibiotics, developing resistances can be avoided. In dermatology, fewer anti-inflammatory drugs would be used. Ultimately, the healing of hard-to-heal wounds such as diabetic foot or postoperative wound healing disorders significantly improves the quality of life of patients.
terraplasma medical GmbH, based in Garching near Munich, was founded in 2016 by terraplasma GmbH, a spin-off of the Max Planck Society. The idea: to use the antimicrobial and tissue-regenerating effect of cold plasma in medicine with a small handheld device for stationary and mobile use. In 2019, the medical product plasma care® was approved for the treatment of chronic wounds, and in 2021 plasma derma care® for the treatment of skin diseases caused by bacteria and fungi. Currently, terraplasma medical is researching and developing other clinical application areas such as dentistry and respiratory infections.
GD Medical is a specialized medical device distributor and wholesaler in the Netherlands, Belgium and Luxemburg with its own strong sales team. The company was founded in 2010 and currently employs 65 people. They welcome innovation and are open to change and improvement. They deliberately do things differently from others and are thus even more of a partner for our customers. They help to keep healthcare costs manageable in an increasingly expensive environment.
Extensive knowledge of the various reimbursement systems, regulations and guidelines, is also one of their strengths.
They believe that it is not only important to supply products, but also to support professionals in treating their patients, optimizing purchasing and making quality products accessible.
terraplasma medical GmbH
Jens Kirsch (CEO)
Parkring 32
85748 Garching b. München
Deutschland
Tel.: +49 (0)89 58805530
info@terraplasma-medical.com
www.terraplasma-medical.com
GD Medical
Roel Claassen (Managing Director)
Hastelweg 224
5652 CL Eindhoven
Netherlands
Tel.: +31 (0)40 3031 090
info@gdmedical.nl
https://www.gdmedical.nl
